Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleBosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.AuthorsGambacorti-Passerini, Carlo; Brümmendorf, Tim H.; Kim, Dong-Wook; Turkina, Anna G.; Masszi, Tamas; Assouline, Sarit; Durrant, Simon; Kantarjian, Hagop M.; Khoury, H. Jean; Zaritskey, Andrey; Shen, Zhi-Xiang; Jin, Jie; Vellenga, Edo; Pasquini, Ricardo; Mathews, Vikram; Cervantes, Francisco; Besson, Nadine; Turnbull, Kathleen; Leip, Eric; Kelly, VirginiaPublicationAmerican Journal of Hematology, 2014, Vol 89, Issue 7, p732ISSN0361-8609Publication typeArticleDOI10.1002/ajh.23728